O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/17/2020ACC: 0001209191-20-037265
Officer· Chief Medical Officer
Since Jun 2018
+54.00
Net shares
Net buyer
$923.67
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
54.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+27.00
Price / share
$34.21
Trade value
$923.67
% of position
1.3%
6/15/2020
2.02K→2.05K
Total
Net shares
+27.00
Net value
$923.67
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2020 | A · Award | +27.00 | $34.21 | $923.67 | 1.3% | 2.02K | 2.05K |
| Total | +27.00 | $923.67 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
27.00 shares
Shares
+27.00
Strike price
40.25
Held after
27.00
Exercisable
—
6/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock27.00 shares | 6/15/2020 | A · Award | +27.00 | 40.25 | — | 27.00 |